BioInvent International AB (publ)
SSE:BINV.ST
16.58 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 71.461 | 326.126 | 19.384 | 147.372 | 93.74 | 38.548 | 45.014 | 71.284 | 15.925 | 46.932 | 81.713 | 42.946 | 124.649 | 82.866 | 80.659 | 252.138 | 143.437 | 50.829 | 28.198 | 58.747 | 66.716 | 87.053 |
Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 2.88 | 0.996 | 1.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 71.461 | 326.126 | 19.384 | 147.372 | 93.74 | 38.548 | 42.134 | 70.288 | 14.275 | 46.932 | 81.713 | 42.946 | 124.649 | 82.866 | 80.659 | 252.138 | 143.437 | 50.829 | 28.198 | 58.747 | 66.716 | 87.053 |
Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 | 0.936 | 0.986 | 0.896 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Reseach & Development Expenses
| 390.434 | 325.929 | 258.337 | 191.421 | 207.896 | 140.182 | 109.723 | 99.477 | 80.502 | 73.372 | 71.18 | 207.278 | 163.904 | 178.89 | 229.187 | 215.434 | 140.861 | 120.524 | 122.678 | 126.087 | 131.049 | 111.682 |
General & Administrative Expenses
| 51.606 | 50.75 | 39.438 | 32.155 | 29.094 | 27.955 | 39.263 | 35.715 | 31.647 | 31.9 | 30.22 | 39.241 | 163.904 | 32.227 | 35.466 | 30.882 | 28.715 | 0.26 | 0.256 | 30.655 | 36.673 | 37.983 |
Selling & Marketing Expenses
| -16.755 | 0 | 0 | 31.639 | 28.576 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 34.851 | 50.75 | 39.438 | 31.639 | 29.094 | 27.955 | 39.263 | 35.715 | 31.647 | 31.9 | 30.22 | 39.241 | 196.461 | 32.227 | 35.466 | 30.882 | 28.715 | 0.26 | 0.256 | 30.655 | 36.673 | 37.983 |
Other Expenses
| -0.022 | -0.081 | -0.226 | -0.731 | -6.249 | -6.504 | -1.617 | -0.671 | -0.612 | -3.422 | -0.896 | -12.201 | -164.056 | -0.411 | -4.492 | -0.749 | -3.54 | 41.982 | 47.508 | 0.017 | -0.26 | -0.196 |
Operating Expenses
| 425.285 | 376.598 | 297.549 | 222.329 | 230.741 | 161.633 | 147.369 | 134.521 | 111.537 | 101.85 | 100.504 | 234.318 | 196.309 | 210.706 | 260.161 | 245.567 | 166.036 | 162.766 | 170.442 | 156.759 | 167.462 | 149.469 |
Operating Income
| -370.579 | -50.921 | -278.35 | -75.474 | -137.848 | -123.232 | -100.632 | -62.859 | -94.973 | -54.925 | -19.176 | -191.093 | -71.66 | -127.84 | -179.502 | 6.571 | 23.449 | -111.73 | -142.334 | -98.102 | 100.746 | 62.416 |
Operating Income Ratio
| -5.186 | -0.156 | -14.36 | -0.512 | -1.471 | -3.197 | -2.236 | -0.882 | -5.964 | -1.17 | -0.235 | -4.45 | -0.575 | -1.543 | -2.225 | 0.026 | 0.163 | -2.198 | -5.048 | -1.67 | 1.51 | 0.717 |
Total Other Income Expenses Net
| 40.479 | 8.418 | -0.094 | -0.859 | -0.785 | -0.078 | 1.827 | 0.65 | 0.584 | 0.933 | 0.752 | 3.527 | 4.607 | -0.56 | 2.841 | 261.818 | 182.129 | 3.104 | 2.382 | 0 | 0 | 0 |
Income Before Tax
| -330.1 | -42.503 | -278.444 | -76.333 | -138.633 | -123.163 | -100.528 | -62.587 | -95.028 | -53.985 | -18.039 | -187.845 | -67.053 | -128.4 | -176.661 | 16.251 | 16.093 | -108.833 | -139.862 | 0 | 0 | 0 |
Income Before Tax Ratio
| -4.619 | -0.13 | -14.365 | -0.518 | -1.479 | -3.195 | -2.233 | -0.878 | -5.967 | -1.15 | -0.221 | -4.374 | -0.538 | -1.549 | -2.19 | 0.064 | 0.112 | -2.141 | -4.96 | 0 | 0 | 0 |
Income Tax Expense
| 0.204 | -8.418 | 0.517 | 0.336 | 0.482 | -0.072 | 0.086 | 0.159 | -4.347 | 0.933 | 0.752 | 3.536 | 4.776 | 0.989 | 3.004 | 261.871 | 221.705 | 3.114 | 2.4 | -64.243 | -257.122 | -195.635 |
Net Income
| -330.304 | -34.085 | -278.961 | -76.669 | -139.115 | -123.163 | -100.528 | -62.587 | -90.681 | -53.985 | -18.039 | -187.845 | -67.053 | -128.4 | -176.661 | 16.251 | -16.093 | -108.833 | -139.862 | -92.516 | 89.66 | 46.166 |
Net Income Ratio
| -4.622 | -0.105 | -14.391 | -0.52 | -1.484 | -3.195 | -2.233 | -0.878 | -5.694 | -1.15 | -0.221 | -4.374 | -0.538 | -1.549 | -2.19 | 0.064 | -0.112 | -2.141 | -4.96 | -1.575 | 1.344 | 0.53 |
EPS
| -5.02 | -0.55 | -5.15 | -2.67 | -7.53 | -9.07 | -8.08 | -6.18 | -16 | -12.01 | -4.73 | -50.31 | -20 | -40.61 | -60.8 | 5.59 | -6.02 | -44.21 | -84.55 | -56.11 | 54.38 | 28.52 |
EPS Diluted
| -5.02 | -0.55 | -5.15 | -2.67 | -7.53 | -8.91 | -8.08 | -6.18 | -15.59 | -12.01 | -4.73 | -50.31 | -20 | -40.61 | -60.8 | 5.59 | -6.02 | -44.21 | -84.54 | -56.11 | 54.38 | 28.52 |
EBITDA
| -353.824 | -27.129 | -263.317 | -63.993 | -126.539 | -118.097 | -99.389 | -62.082 | -93.835 | -51.944 | -15.143 | -181.698 | -60.579 | -117.479 | -165.381 | 27.847 | 35.795 | -93.404 | -119.549 | -135.795 | -148.595 | -135.994 |
EBITDA Ratio
| -4.951 | -0.083 | -13.584 | -0.434 | -1.35 | -3.064 | -2.208 | -0.871 | -5.892 | -1.107 | -0.185 | -4.231 | -0.486 | -1.418 | -2.05 | 0.11 | 0.25 | -1.838 | -4.24 | -2.312 | -2.227 | -1.562 |